AstraZeneca Vaccine Effective Against U.K. Variant in Trial

The vaccine jointly developed by the University of Oxford and AstraZeneca worked against a highly transmissible variant of the coronavirus first spotted in the U.K. in a clinical trial, the university said.The vaccine jointly developed by the University of Oxford and AstraZeneca worked against a highly transmissible variant of the coronavirus first spotted in the U.K. in a clinical trial, the university said.Read MorePAIDWSJ.com: US Business